Law firms Cravath and Kirkland ride pharma wave to win places on $5.8bn Abbott-Alere deal Legal Business · 1 February 2016 · 1 min read Corporate and M&A Cravath, Swaine & Moore Kirkland & Ellis Already two of the big winners from the merger bonanza in the pharmaceuticals sector, Cravath, Swaine & Moore and Kirkland & Ellis have won mandates advising on the $5.8bn purchase of diagnostic testing company Alere by Abbott Laboratories.Your limit of 1 article in 30 days is up. Please login for full access or subscribe. Corporate users - click here for simple access (no password needed). For more information, please contact [email protected] Related ContentMore in this category‘Seismic changes’ – breaking down the Weil US exits as firmwide departures near 30Law firm dataAlex Ryan16 Sep 2026Sullivan & Cromwell hires four-partner Kirkland team for PE pushLaw firmsKate Peacock15 Sep 2026Full details – the six M&A partners set to leave Weil for CravathLaw firmsKate Peacock11 Sep 2026Senior CEE partner leaves Freshfields for White & CaseLaw firmsEliza Winter18 Sep 2026Latham and Sidley lead as Boehly and Walter exit Chelsea investmentLaw firmsWill Lewallen17 Sep 2026Weil London M&A stars set to join Sullivan & Cromwell as exits mountLaw firmsKate Peacock16 Sep 2026Revolving doors: Simpson Thacher, Latham, Sidley lead New Year London movesLaw firmsAnna Huntley9 Jan 2025Five partners vie to succeed Hoyland as Simmons managing partnerLaw firmsTom Cox7 Jan 2025‘Seize every opportunity’ – Paul Hastings partner Reena Gogna on City law, Suits and poetryLaw firmsAnna Huntley7 Jan 2025